Rooms Trade App.
All rights reserved. See Brickell Biotech price target based on analysts offering 12 month price targets for Brickell Biotech in the last 3 months. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Our methodology considers analysis of the company's financial situation and how it … Sofpironium Bromide is a topical soft anticholinergic ...Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes.
The firm’s total holdings are worth over $433.07 Thousand and represent 3.76% of shares outstanding. 50-Day Range N/A. The 3-month trading volume is 1.48 Million shares.
The BBI stock price is -238.18% off its 52-week high price of $6.51 and 48.57% above the 52-week low of $0.99. The expected earnings per share for the stock is $0.Insiders own 14.31% of the company shares, while shares held by institutions stand at 31.99% with a share float percentage of 37.33%. The projected low price target is $12.6 while the price target rests at a high of $12.6. As of March 30, 2020, Palisade Capital Management, L.L.C. Average Volume739,419 shs. BBI Stock Forecast - Get a free BBI stock predictions and find out whether you should buy or sell BBI stock. Earnings growth for 2020 is a modest +13.6%.Despite being -6.31% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jul 08 when the BBI stock price touched $0.9559 or saw a rise of 11.79%. Trending now. Find real-time BBI - Brickell Biotech Inc stock quotes, company profile, news and forecasts from CNN Business. 52-Week Range N/A. The Company’s product candidates include BBI-3000, BBI-6000 and Sofpironium Bromide. BBI 0.90 0.04 (4.37%) NASDAQ Updated Jul 24, 2020 6:09 PM. 1 out of 1 have rated it as a Hold, with no one of them advising it as a Buy. Click here for a FREE analysis on BBI. The BBI stock will be analyzed using Smart Scan and the Trade Triangle technology. In the short term (2weeks), BBI's stock price should outperform the market by 5.90%. None have rated the stock as Underweight. The top two institutional holders are Palisade Capital Management, L.L.C. Over the past 30 days, the shares of Brickell Biotech, Inc. (NASDAQ:BBI) have changed -33.08%. If we look at the company’s 10-day average daily trading volume, we find that it stood at 821.32 Million shares traded. Add. The trend analysis tool will help you make a better prediction on the BBI stock. NASDAQ 0.00%. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Year-to-date, Brickell Biotech, Inc. shares have moved 30.67%, while the 5-day performance has seen it change 66.1%. The company, currently valued at $8.16 Million, closed the last trade at $0.84 per share which meant it lost $0 on the day or -6.31% during that session. Our methodology considers analysis of the company's financial situation and how it …
As of March 30, 2020, Palisade Capital Management, L.L.C. Cancel. In that case, then, we find that the current price level is +1400% off the targeted high while a plunge would see the stock lose 1400% from current levels.The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 363.92 Thousand shares as of March 30, 2020. Short interest in the company has seen 134.44 Million shares shorted with days to cover at 90.84.Wall Street analysts have a consensus price target for the stock at $12.6, which means that the shares’ value could jump 1400% from current levels.
If we look at the company’s 10-day average daily trading volume, we find that it stood at 821.32 Million shares traded. 5,872 Watchers. The BBI stock forecast is provided by MarketClub with their Trade Triangle system. In that case, then, we find that the current price level is +554.55% off the targeted high while a plunge would see the stock lose 554.55% from current levels. held 9.83% of shares outstanding.Brickell Biotech, Inc. (NASDAQ:BBI) has seen 1,598,783 shares traded in the last trading session. Follow BBI to track price target and stock forecast updates from top …
Your current $100 investment may be up to $72986.74 in 2025. BBI Stock Predictions. If we look at the company’s 10-day average daily trading volume, we find that it stood at 830.05 Million shares traded. BBI Stock Predictions. Should I buy or sell BBI?
Volume480,752 shs. The trend analysis tool will help you make a better prediction on the BBI stock.